Moreover, the symptoms of the central nervous system behave before mucosal symptoms and detection of anti-SSA/SSB antibody in pSS patients with NMOSD (9–11), which may result in ignoring the existence and treatment of pSS. This evidence concerns the gene CALR and peeling skin syndrome.